SCHEMBL19689533

SCHEMBL19689533

Fc1cc(Cl)c(-c2noc(C3CC3)c2CCl)c(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 20/20 0.44
FABP1 P07148 3/20 0.40
HSD17B13 Q7Z5P4 1/20 0.40
FABP4 P15090 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28320904 0.88 NR1H4 (0.46) NR1H4FABP1HSD17B13FABP4
SCHEMBL19689512 0.88 NR1H4 (0.46) NR1H4FABP1HSD17B13FABP4
SCHEMBL12168751 0.83 NR1H4 (0.47) NR1H4
SCHEMBL12168749 0.83 NR1H4 (0.55) NR1H4FABP1HSD17B13FABP4
SCHEMBL21216847 0.83 NR1H4 (0.45) NR1H4FABP1HSD17B13FABP4
SCHEMBL19705737 0.81 NR1H4 (0.47) NR1H4FABP1HSD17B13
SCHEMBL24565512 0.80 NR1H4 (0.46) NR1H4FABP1HSD17B13
SCHEMBL28870286 0.80 NR1H4 (0.43) NR1H4FABP1HSD17B13
SCHEMBL12168750 0.80 NR1H4 (0.40) NR1H4FABP1HSD17B13FABP4
SCHEMBL28241510 0.79 NR1H4 (0.43) NR1H4FABP1FABP4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4691553-A2 FXR (NR1H4) MODULATING COMPOUNDS Gilead Sciences, Inc. (US) 2026-02-11 EP disclosed
EP-4534536-A1 FXR (NR1H4) MODULATING COMPOUNDS Gilead Sciences, Inc. (US) 2025-04-09 EP disclosed
US-20250026744-A1 FXR (NR1H4) MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2025-01-23 US disclosed
EP-3746448-B1 NITROGENOUS TRICYCLIC COMPOUNDS AND USES THEREOF IN MEDICINE SUNSHINE LAKE PHARMA CO LTD (CN) 2025-01-15 EP disclosed
CN-113302190-B FXR (NR 1H 4) modulating compounds 吉利德科学公司 2024-10-18 CN disclosed
EP-4089072-B1 FXR (NR1H4) MODULATING COMPOUNDS GILEAD SCIENCES INC (US) 2024-08-28 EP disclosed
EP-4360632-A2 FXR (NR1H4) MODULATING COMPOUNDS Gilead Sciences, Inc. (US) 2024-05-01 EP disclosed
CN-117924266-A Compounds that modulate FXR (NR 1H 4) 吉利德科学公司 2024-04-26 CN disclosed
CN-117924267-A Compounds that modulate FXR (NR 1H 4) 吉利德科学公司 2024-04-26 CN disclosed
CN-109476636-B Compounds that modulate FXR (NR 1H 4) 吉利德科学公司 2024-01-09 CN disclosed
EP-3257847-B1 FXR (NR1H4) MODULATING COMPOUNDS GILEAD SCIENCES INC (US) 2019-08-21 EP disclosed
EP-3257847-B1 FXR (NR1H4) MODULATING COMPOUNDS GILEAD SCIENCES INC (US) 2019-08-21 EP disclosed
CN-109476636-A Compounds that modulate FXR (NR1H4) 吉利德科学公司 2019-03-15 CN disclosed
WO-2017218330-A1 FXR (NR1H4) MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2017-12-21 WO disclosed
WO-2017218330-A1 FXR (NR1H4) MODULATING COMPOUNDS GILEAD SCIENCES, INC. (US) 2017-12-21 WO disclosed
EP-3257847-A1 FXR (NR1H4) MODULATING COMPOUNDS Gilead Sciences, Inc. (US) 2017-12-20 EP disclosed
EP-3257847-A1 FXR (NR1H4) MODULATING COMPOUNDS Gilead Sciences, Inc. (US) 2017-12-20 EP disclosed
US-20170355685-A1 FXR (NR1H4) MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2017-12-14 US disclosed
US-20170355685-A1 FXR (NR1H4) MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2017-12-14 US disclosed
US-20170355685-A1 FXR (NR1H4) MODULATING COMPOUNDS GILEAD SCIENCES, INC. 2017-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250026744-A1 FXR (NR1H4) MODULATING COMPOUNDS NR1H4, NR1H2, NR1H3 NR1H4 1/4885FABP1 15/4885HSD17B13 707/4885
US-20170355685-A1 FXR (NR1H4) MODULATING COMPOUNDS NR1H4, NR1H2, NR1H3 NR1H4 1/4885FABP1 15/4885HSD17B13 681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.